Keith Westby - Feb 1, 2023 Form 4 Insider Report for IVERIC bio, Inc. (ISEE)

Role
SVP, Chief Operating Officer
Signature
/s/ Todd D.C. Anderman, as Attorney-in-Fact for Keith Westby
Stock symbol
ISEE
Transactions as of
Feb 1, 2023
Transactions value $
-$937,000
Form type
4
Date filed
2/3/2023, 03:26 PM
Previous filing
Jan 4, 2023
Next filing
Feb 22, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ISEE Common Stock Sale -$461K -20K -23.16% $23.03 66.4K Feb 1, 2023 Direct F1, F2
transaction ISEE Common Stock Sale -$476K -20K -30.14% $23.82 46.4K Feb 2, 2023 Direct F1, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The sale reported on this form was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 16, 2022.
F2 The sale price of the Reporting Person's shares represents the weighted average price of all shares sold by a broker in multiple transactions effected at prices ranging from $22.63 to $23.16 per share on February 1, 2023. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Registrant or a security holder of the Registrant, information regarding the number of shares sold at each price within the range.
F3 The sale price of the Reporting Person's shares represents the weighted average price of all shares sold by a broker in multiple transactions effected at prices ranging from $23.55 to $24.25 per share on February 2, 2023. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Registrant or a security holder of the Registrant, information regarding the number of shares sold at each price within the range.